Related references
Note: Only part of the references are listed.Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2020)
Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke
Geoffrey Urbanski et al.
STROKE (2018)
Incidence of thromboembolic events in asymptomatic carriers of IgA anti β2 glycoprotein-I antibodies
Carlos Tortosa et al.
PLOS ONE (2017)
A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study
Julius S. Ngwa et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE
Vinicius Domingues et al.
LUPUS SCIENCE & MEDICINE (2016)
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Ozan Unlu et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2016)
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
Johanna Gebhart et al.
BLOOD (2015)
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant
Vittorio Pengo et al.
THROMBOSIS RESEARCH (2015)
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis
Quitterie Reynaud et al.
AUTOIMMUNITY REVIEWS (2014)
A 2014 update on the management of patients with systemic lupus erythematosus
Joan T. Merrill et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Isolated IgA Anti-beta 2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
Raquel Ruiz-Garcia et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome
Vijaya Murthy et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities
S. Sciascia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
IgM Anti-β2 Glycoprotein I Is Protective Against Lupus Nephritis and Renal Damage in Systemic Lupus Erythematosus
Taraneh Mehrani et al.
JOURNAL OF RHEUMATOLOGY (2011)
Association of IgA Anti-beta 2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus
Taraneh Mehrani et al.
JOURNAL OF RHEUMATOLOGY (2011)
IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
Nadera J. Sweiss et al.
PLOS ONE (2010)
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
M. GALLI et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
Rolf T. Urbanus et al.
LANCET NEUROLOGY (2009)
IgA antiphospholipid antibodies are an independent risk factor for thromboses
Y. M. Shen et al.
LUPUS (2008)
A comparison of lupus anticoagulant-positive patients with clinical picture of Antiphospholipid syndrome and those without
Vittorio Pengo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Revised classification criteria for anti phospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
J. Swadzba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Monica Galli et al.
BLOOD (2007)
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus
Agustin Martincz-Berriotxoa et al.
LUPUS (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus
C Male et al.
BLOOD (2005)
Antibody profiles for the diagnosis of anti phospholipid syndrome
V Pengo et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
PG De Groot et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Epidemiology of the antiphospholipid antibody syndrome
M Petri
JOURNAL OF AUTOIMMUNITY (2000)